[1] HEYMANN F,HAMESCH K,WEISKIRCHEN R,et al. The concanavalin A model of acute hepatitis in mice[J]. Lab Anim,2015,49(Sup 1):12-20. [2] LEIST M,WENDEL A. A novel mechanism of murine hepatocyte death inducible by concanavalin A[J]. J Hepatol,1996,25(6):948-959. [3] KNOLLE P A,GERKEN G,LOSER E,et al. Role of sinusoidal endothelial cells of the liver in concanavalin A-induced hepatic injury in mice[J]. Hepatology,1996,24(4):824-829. [4] TIEGS G,HENTSCHEL J,WENDEL A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A[J]. J Clin Invest,1992,90(1):196-203. [5] BALLERSTADT R,EVANS C,MCNICHOLS R,et al. Concanavalin A for in vivo glucose sensing:a biotoxicity review[J]. Biosens Bioelectron,2006,22(2):275-284. [6] WANG H X,LIU M,WENG S Y,et al. Immune mechanisms of concanavalin A model of autoimmune hepatitis[J]. World J Gastroenterol,2012,18(2):119-125. [7] DAVID B A,REZENDE R M,ANTUNES M M,et al. Combination of mass cytometry and imaging analysis reveals origin,location,and functional repopulation of liver myeloid cells in mice[J]. Gastroenterology,2016,151(6):1176-1191. [8] FECHTNER S,FOX D A,AHMED S. Transforming growth factor beta activated kinase 1:a potential therapeutic target for rheumatic diseases[J]. Rheumatology (Oxford),2017,56(7):1060-1068. [9] ROH Y S,SONG J,SEKI E. TAK1 regulates hepatic cell survival and carcinogenesis[J]. J Gastroenterol,2014,49(2):185-194. [10] IKEDA Y,MORIOKA S,MATSUMOTO K,et al. TAK1 binding protein 2 is essential for liver protection from stressors[J]. PLoS One,2014,9(2):e88037. [11] MORIOKA S,SAI K,OMORI E,et al. TAK1 regulates hepatic lipid homeostasis through SREBP[J]. Oncogene,2016,35(29):3829-3838. [12] SONG I J,YANG Y M,INOKUCHI-SHIMIZU S,et al. The contribution of toll-like receptor signaling to the development of liver fibrosis and cancer in hepatocyte-specific TAK1-deleted mice[J]. Int J Cancer,2018,142(1):81-91. [13] PAN Y,LEI Z,WEI X,et al. TAK1 deficiency in dendritic cells inhibits adaptive immunity in SRBC-immunized C57BL/6 mice[J]. FEBS Open Biol,2016,6(6):548-557. [14] 刘应莉. 骨髓间充质干细胞治疗小鼠自身免疫性肝炎的实验研究[D]. 天津:天津医科大学,2012. [15] ROTH R A,CASSELL D J,MADDUX B A,et al. Regulation of insulin receptor kinase activity by insulin mimickers and an insulin antagonist[J]. Biochem Biophys Res Commun,1983,115(1):245-252. [16] WANG Y,HUANG G,VOGEL P,et al. Transforming growth factor beta-activated kinase 1(TAK1)-dependent checkpoint in the survival of dendritic cells promotes immune homeostasis and function[J]. Proc Natl Acad Sci U S A,2012,109(6):343-E352. [17] TOMIYAMA C,WATANABE H,IZUTSU Y,et al. Suppressive role of hepatic dendritic cells in concanavalin A-induced hepatitis[J]. Clin Exp Immunol,2011,166(2):258-268. [18] WANG J,CAO X,ZHAO J,et al. Critical roles of conventional dendritic cells in promoting T cell-dependent hepatitis through regulating natural killer T cells[J]. Clin Exp Immunol,2017,188(1):127-137. [19] 杨敬宁,赵杰. 浆细胞样树突状细胞与免疫耐受[J]. 国际免疫学杂志,2012,35(4):273-276. [20] 陈旭央,张冰,胡莉蔓. IL-17、IL-5、IL-4、IL-33等细胞因子在哮喘发病机制中的作用[J]. 中国医药导报,2015,12(14):98-101. [21] HAMELMANN E,GELFAND E W. Role of IL-5 in the development of allergen-induced airway hyperresponsiveness[J]. Int Arch Allergy Immunol,1999,120(1):8-16. [22] 赵桐,杨安钢,温伟红. IL-12用于肿瘤基因治疗的研究进展[J]. 细胞与分子免疫学杂志,2015,31(10):1424-1428. |